Breaking Down Satellite Chemical Co.,Ltd. Financial Health: Key Insights for Investors

Peeling back the numbers on Satellite Chemical Co., Ltd. (002648.SZ) reveals a company growing fast yet carrying meaningful leverage-first-half 2025 revenue hit 23.46 billion yuan (up 20.93% year-on-year) while TTM revenue through Sept 2025 reached 48.14 billion yuan (up 15.42%), powered largely by a 32.12% surge in functional chemicals that contributed 12.217 billion yuan; profitability is robust with H1 net profit attributable at 2.744 billion yuan (up 33.44%), TTM net income of 6.134 billion yuan (net margin ~12.74%), an EPS (TTM) of 1.81 yuan and a P/E of 9.09, and a strong ROE of 20.46%, yet the balance sheet shows total debt of 23.58 billion yuan against cash of 8.51 billion (net debt 15.07 billion), a debt-to-equity of 0.78 and interest coverage of 8.01 while liquidity metrics (current ratio 0.81, quick ratio 0.52) and negative net working capital flag short-term constraints-valuation multiples (market cap 55.15 billion yuan, EV 72.92 billion, EV/EBITDA 5.65, P/S ~1.15) suggest potential undervaluation, and regulatory, commodity and volatility risks (beta 1.092; U.S. Department of Commerce notices to Satellite Chemical USA) add caution-read on to see how these figures translate into investment implications.

Satellite Chemical Co.,Ltd. (002648.SZ) Revenue Analysis

Satellite Chemical's top-line shows sustained expansion driven primarily by its functional chemicals segment and steady operational leverage.

• H1 2025 revenue: 23.46 billion yuan (YoY +20.93%).
• TTM revenue as of Sep 2025: 48.14 billion yuan (TTM YoY +15.42%).
• Full-year growth history: 2024 +10.03%; 2023 +12.00%.
• Functional chemicals contribution: 12.217 billion yuan in H1 2025 (YoY +32.12%).
• Revenue per employee: ~9.52 million yuan.
• Market capitalization: 55.15 billion yuan; P/S ratio: 1.16.

Key revenue drivers and implications:

• The functional chemicals segment is the primary growth engine-contributing ~52% of H1 2025 revenue (12.217/23.46 ≈ 52.07%) and growing >32% YoY.
• TTM growth of 15.42% indicates momentum beyond a single half-year spike, consistent with multi-year growth (2023-2024 trend).
• Revenue per employee (~9.52 million yuan) signals high productivity and capital-/technology-driven operations rather than labor intensity.
• Valuation context: market cap 55.15 billion yuan vs. TTM sales 48.14 billion yuan → P/S ≈ 1.16, suggesting a moderate premium relative to revenue given the company's above-market growth in key segments.

For more context on corporate background and how Satellite Chemical operates, see: Satellite Chemical Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Satellite Chemical Co.,Ltd. (002648.SZ) - Profitability Metrics

• First half 2025 net profit attributable to shareholders: 2.744 billion yuan (up 33.44% year-on-year).
• TTM net income as of September 2025: 6.134 billion yuan; net margin ≈ 12.74%.
• Quarter ending 31-Mar-2025 operating income: 2.178 billion yuan; operating margin: 17.66%.
• Return on equity (ROE): 20.46%.
• TTM earnings per share (EPS): 1.81 yuan; P/E ratio: 9.09.
• 5-year operating income CAGR: 43%.

• High ROE (20.46%) and expanding margins indicate efficient use of equity and strong operational leverage.
• Relatively low P/E (9.09) versus earnings (EPS 1.81 yuan) suggests potential valuation upside if growth sustains.
• Rapid operating income CAGR (43% over 5 years) underpins the sizeable YoY net profit increase in H1 2025.

Satellite Chemical Co.,Ltd. (002648.SZ) - Debt vs. Equity Structure

Key balance-sheet and liquidity indicators for Satellite Chemical Co.,Ltd. (002648.SZ) highlight a capital structure with moderate leverage, healthy operating cash flow and targeted capex spending as the company executes expansion plans.

• Total debt: 23.58 billion yuan
• Cash and equivalents: 8.51 billion yuan
• Net debt: 15.07 billion yuan
• Debt-to-equity ratio: 0.78
• Interest coverage ratio: 8.01
• Operating cash flow: 10.59 billion yuan
• Capex ≈ 6.9% of revenue
• Total debt change (YoY): +35%

How these numbers interact:

• Net debt (15.07 bn) relative to operating cash flow (10.59 bn) implies roughly 1.42x OCF coverage of net debt-indicating workable deleveraging capacity if cash flow is sustained.
• Interest coverage of 8.01 provides ample buffer for interest payments, lowering immediate refinancing risk despite the 35% YoY debt increase.
• Capex at ~6.9% of revenue signals controlled investment, limiting further immediate strain on free cash flow while supporting growth.

For additional investor context and ownership dynamics, see: Exploring Satellite Chemical Co.,Ltd. Investor Profile: Who's Buying and Why?

Satellite Chemical Co.,Ltd. (002648.SZ) - Liquidity and Solvency

• Current ratio: 0.81 - current assets cover 81% of current liabilities, signaling potential short-term liquidity pressure.
• Quick ratio: 0.52 - excluding inventory, only 52% of immediate liabilities can be met, indicating reliance on inventory conversion or operating cash flow.
• Operating cash flow: ¥10.59 billion - a substantial cash inflow that supports working capital needs, capex and debt servicing.
• Net working capital: negative - current liabilities exceed current assets, reflecting short-term constraint and the need for continued cash generation or financing.
• Interest coverage ratio: 8.01 - operating earnings cover interest expense ~8x, indicating comfortable near-term interest-servicing capacity.
• Operating income growth: CAGR 43% (5 years) - rapid top-line/operational improvement enhancing long-term solvency outlook if sustained.

• Key operational strength: high operating cash flow and 43% operating income CAGR support deleveraging and liquidity improvement over time.
• Key risk: sub-1 current ratio and negative net working capital create dependence on continued strong cash flow, inventory turnover, or external financing.
• Debt service profile: interest coverage of 8.01 provides a buffer, but monitoring of cash conversion and near-term maturities is crucial.

Satellite Chemical Co.,Ltd. (002648.SZ) - Valuation Analysis

• TTM Price-to-Earnings (P/E): 9.09 - implies the market is pricing the company at roughly 9.09 times trailing earnings, a level often interpreted as potential undervaluation for a high-ROE chemical firm.
• Forward P/E: 7.97 - lower than TTM P/E, suggesting expected earnings growth or further re-rating opportunity.
• Price-to-Sales (P/S): 1.15 - indicates the stock is trading at just over one times annual sales, a reasonable multiple for the sector.
• EV/EBITDA: 5.65 - a moderate enterprise-value multiple pointing to attractive valuation versus operational cash profitability.
• Market Capitalization: ¥55.15 billion; Enterprise Value (EV): ¥72.92 billion - EV reflects debt and minority interests beyond market cap.
• EPS (TTM): ¥1.81 - combined with the TTM P/E of 9.09, reinforces the earnings-based valuation level.
• Return on Equity (ROE): 20.46% - strong profitability relative to shareholders' equity, supporting a premium vs. peers despite low P/E.

• Relative valuation context: the combination of a low P/E, modest P/S and EV/EBITDA, and a high ROE suggests Satellite Chemical may be undervalued relative to earnings and capital efficiency.
• Investor considerations: monitor forward earnings guidance driving the forward P/E, leverage and net debt components embedded in EV, and comparatives vs. chemical-sector peers to assess margin of safety.

Satellite Chemical Co.,Ltd. (002648.SZ) - Risk Factors

• Regulatory / geopolitical disruption: The U.S. Department of Commerce has issued letters to Satellite Chemical USA (a subsidiary) prohibiting the unloading of ethane shipments in China without specific authorization - a direct supply-chain and feedstock risk that can delay production, raise procurement costs, or force alternative (often more expensive) feedstock sourcing.
• Market volatility: The company's beta is 1.092, implying higher sensitivity to broad-market moves and greater downside volatility in risk-off environments.
• Sector cyclicality: As a chemical producer, Satellite Chemical is exposed to economic cycles and raw-material price swings (e.g., ethane/ethylene, naphtha). These input-cost pass-through dynamics can compress margins during downturns.
• Leverage and liquidity strain: Total debt stands at 23.58 billion yuan, cash reserves at 8.51 billion yuan, producing net debt of 15.07 billion yuan - a levered position that reduces financial flexibility, especially if operating cash flow weakens.
• Short-term liquidity ratios: Current ratio of 0.81 and quick ratio of 0.52 indicate potential difficulty meeting near-term liabilities from current assets without asset sales or refinancing.
• Operational concentration and feedstock dependency: A reliance on specific feedstock logistics (highlighted by the ethane shipment restriction) magnifies operational risk and could force higher-cost substitutes.
• Growth vs. capital intensity: Operating income has grown at a 43% CAGR over the past five years - a strong growth signal but one that may have required significant capex and working-capital investment, intensifying funding needs and exposure to commodity cycles.

• Refinancing risk: Elevated net debt and sub-1.0 liquidity ratios increase sensitivity to credit-market conditions and interest-rate moves.
• Cash-flow volatility: Input-price spikes or production interruptions (e.g., ethane supply constraints) can quickly erode free cash flow and stress covenant metrics.
• Counterparty and logistics risk: Restrictions on specific shipments elevate counterparty, port, and logistics counterparty risk across the value chain.
• Investor return variability: Higher beta and sector cyclicality suggest potential for greater share-price swings despite robust historical operating-income growth.

Satellite Chemical Co.,Ltd. (002648.SZ) - Growth Opportunities

Satellite Chemical's strategic push into functional chemicals is driving a meaningful portion of revenue and improving unit economics. The segment delivered a 32.12% year-on-year increase and contributed 12.217 billion yuan to total revenue, underlining product mix improvement and higher-margin sales.

• Functional chemicals revenue: 12.217 billion yuan (+32.12% YoY)
• 5-year operating income CAGR: 43% (reflecting sustained top-line expansion and operational leverage)
• Trailing twelve months EPS: 1.81 yuan, P/E: 9.09 (suggesting relative undervaluation versus earnings)
• Return on Equity (ROE): 20.46% (strong profitability vs. shareholders' equity)

Key valuation and capital structure metrics provide context for investors assessing growth runway and acquisition/expansion feasibility.

• Growth drivers: higher-margin functional chemicals, scale benefits from rapid operating-income growth, and disciplined capital allocation implied by elevated ROE.
• Valuation opportunity: P/E 9.09 vs. solid EPS suggests upside if earnings momentum continues.
• Balance of valuation and EV: Market cap 55.15B vs. EV 72.92B highlights leverage and non-equity claims-monitor net debt trends as expansion continues.

For corporate direction and values that contextualize strategic choices, see Mission Statement, Vision, & Core Values (2026) of Satellite Chemical Co.,Ltd.